Gènes Diffusion, a leading global animal reproductive company, is pleased to announce the acquisition of ReproQuest. ReproQuest is a veterinary biotech company specializing in the development, manufacture, and sale of artificial insemination products for swine.
For nearly a decade, ReproQuest has played an integral part in the A.I. industry providing swine producers worldwide with products that deliver exceptional quality and performance at competitive prices.
With this acquisition, Genes Diffusion has established a newly formed subsidiary company, GenePro Inc. Dr. Kevin Rozeboom, former President and CEO of ReproQuest, has been hired as the V.P. of Operations and Business Development for GenePro Inc. The hiring of Dr. Rozeboom will permit GenePro Inc. to provide uninterrupted service to ReproQuests' loyal customer base.
Regarding the acquisition, Claude Grenier Development Manager of Genes Diffusion, commented;
"This strategic acquisition will create greater efficiencies for the Genes Diffusion Group and its partners worldwide and accelerate delivery of key swine A.I. products. In addition, GenePro Inc. is the ideal platform for the commercial launch of our upcoming line of innovative swine A.I. technologies".
Kevin Rozeboom added:
"I believe that the services provided by our respective corporations to the swine industry is complementary and that each strategically benefits from the other's expertise and business activities. The acquisition of ReproQuest by Genes Diffusion Group, thereby creates a world leading A.I. manufacturing, Research and Genetic management company".
Founded in 1948, Genes Diffusion specializes in the genetics and animal reproduction of bovine, porcine, equine and rabbit species. Genes Diffusion's highly acclaimed line of swine A.I. products is world renown in the swine artificial insemination industry for their innovation and technological advancement.
The Genes Diffusion Group's other U.S. Subsidiary, Genes Diffusion USA, is active in Boar Stud Management/Consultation, Quality Assurance/Quality Control Services as well as the marketing of dairy and beef genetics, bovine embryos and semen for the international industry.
Key Figures on Genes Diffusion Groupe: 86 million US$ equity, 115 million US$ turnover, 30,000 clients